Patent US5746206A successfully refreshed from Google Patents.
US5746206A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Isolated layer pulse oximetry
Assignee: Nellcor Inc
•
Filing: 1996-06-10
•
Granted: 1998-05-05
•
Expires: 2016-06-10
Abstract
Abstract An apparatus of and method for measuring arterial blood oxygen saturation at a particular tissue level of interest. Visible and near infrared radiation is emitted into a patient at the measurement site using two different wavelengths. Detection at two different detection sites permits rejection of oxygen saturation at undesired tissue levels.
Inventors
- 👤 Paul D. Mannheimer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 00:11
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/145; A61B5/1455; A61B5/14551; G; G01; G01N; G01N21/00; G01N21/17; G01N21/25; G01N21/31; G01N21/314; G01N21/47; G01N21/49; A61B2562/00; A61B2562/02; A61B2562/0233; A61B2562/0242; A61B5/14552
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
124 words
An apparatus comprising: a. a patient interface adapted to be coupled to a patient; b. an emitter of electromagnetic radiation coupled to said patient interface; c. a first detector coupled to said patient interface at a first distance from said emitter; d. a second detector coupled to said patient interface at a second distance from said emitter; e. means for synchronizing an oxygen saturation measurement to a predetermined portion of a cardiac cycle of said patient; and f. means coupled to said first and said second detectors and said synchronizer for computing an oxygen saturation level of arterial blood of said patient, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level.
Claim 2
Independent Claim
124 words
An apparatus comprising: a. a patient interface adapted to be coupled to a patient; b. an emitter of electromagnetic radiation coupled to said patient interface; c. a first detector coupled to said patient interface at a first distance from said emitter; d. a second detector coupled to said patient interface at a second distance from said emitter; e. means for synchronizing an oxygen saturation measurement to a predetermined portion of a cardiac cycle of said patient; and f. means coupled to said first and said second detectors and said synchronizer for computing an oxygen saturation level of arterial blood of said patient, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level.
Claim 3
Dependent Claim
18 words
An apparatus according to claim 1 wherein said emitter emits a plurality of predetermined wavelengths of electromagnetic radiation.
Claim 4
Dependent Claim
16 words
An apparatus according to claim 2 wherein said emitter emits two predetermined wavelengths of electromagnetic radiation.
Claim 5
Dependent Claim
138 words
A pulse oximeter apparatus for calculating arterial oxygen saturation, comprising: a. a patient interface adapted to be coupled to a patient and including at least three sensor areas for emitting electromagnetic radiation which penetrates tissue of the patient and detects that electromagnetic radiation scattered by the tissue, a first spacing being between a first combination of electromagnetic emitter which emits at least two wavelengths and electromagnetic detector a second spacing being between a second combination of electromagnetic emitter which emits at least two wavelengths and electromagnetic detector, the first spacing being different from the second spacing; and b. means for calculating an arterial oxygen saturation level of the patient in response to the detected electromagnetic radiation, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level.
Claim 6
Dependent Claim
138 words
A pulse oximeter apparatus for calculating arterial oxygen saturation, comprising: a. a patient interface adapted to be coupled to a patient and including at least three sensor areas for emitting electromagnetic radiation which penetrates tissue of the patient and detects that electromagnetic radiation scattered by the tissue, a first spacing being between a first combination of electromagnetic emitter which emits at least two wavelengths and electromagnetic detector a second spacing being between a second combination of electromagnetic emitter which emits at least two wavelengths and electromagnetic detector, the first spacing being different from the second spacing; and b. means for calculating an arterial oxygen saturation level of the patient in response to the detected electromagnetic radiation, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level.
Claim 7
Independent Claim
234 words
A method of measuring oxygen saturation level of arterial blood at a measurement site of a patient comprising: a. determining a time of arrival of an arterial pulse wavefront at the measurement site of the patient; b. emitting a first wavelength of electromagnetic radiation at the measurement site of the patient; c. measuring an amplitude of the first wavelength of electromagnetic radiation at a first detector located at a first distance from the measurement site; d. measuring an amplitude of the first wavelength of electromagnetic radiation at a second detector located at a second distance from the measurement site; e. emitting a second wavelength of electromagnetic radiation at the measurement site of the patient; f. measuring an amplitude of the second wavelength of electromagnetic radiation at the first detector located at the first distance from the measurement site; g. measuring an amplitude of the second wavelength of electromagnetic radiation at the second detector located at the second distance from the measurement site; h. computing an arterial oxygen saturation level, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level, using the amplitudes of the first wavelength measured at the first detector and the second detector, using the amplitudes of the second wavelength measured at the first detector and the second detector, and rejecting oxygen saturation level of venous blood of the patient.
Claim 8
Independent Claim
234 words
A method of measuring oxygen saturation level of arterial blood at a measurement site of a patient comprising: a. determining a time of arrival of an arterial pulse wavefront at the measurement site of the patient; b. emitting a first wavelength of electromagnetic radiation at the measurement site of the patient; c. measuring an amplitude of the first wavelength of electromagnetic radiation at a first detector located at a first distance from the measurement site; d. measuring an amplitude of the first wavelength of electromagnetic radiation at a second detector located at a second distance from the measurement site; e. emitting a second wavelength of electromagnetic radiation at the measurement site of the patient; f. measuring an amplitude of the second wavelength of electromagnetic radiation at the first detector located at the first distance from the measurement site; g. measuring an amplitude of the second wavelength of electromagnetic radiation at the second detector located at the second distance from the measurement site; h. computing an arterial oxygen saturation level, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level, using the amplitudes of the first wavelength measured at the first detector and the second detector, using the amplitudes of the second wavelength measured at the first detector and the second detector, and rejecting oxygen saturation level of venous blood of the patient.
Claim 9
Independent Claim
230 words
A method of measuring a blood characteristic at a measurement site of a patient comprising: a. determining a time of arrival of an arterial pulse wavefront at the measuring site of the patient; b. emitting a first wavelength of electromagnetic radiation at the measurement site of the patient; c. measuring an intensity of the first wavelength of electromagnetic radiation at a first detector located at a first distance from the measurement site; d. measuring an intensity of the first wavelength of electromagnetic radiation at a second detector located at a second distance from the measurement site; e. emitting a second wavelength of electromagnetic radiation at the measurement site of the patient; f. measuring an intensity of the second wavelength of electromagnetic radiation at the first detector located at the first distance from the measurement site; g. measuring an intensity of the second wavelength of electromagnetic radiation at the second detector located at the second distance from the measurement site; h. determining a blood characteristic level, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level, using the intensities of the first wavelength measured at the first detector and the second detector, using the intensities of the second wavelength measured at the first detector and the second detector, and rejecting blood characteristic level of venous blood of the patient.
Claim 10
Independent Claim
230 words
A method of measuring a blood characteristic at a measurement site of a patient comprising: a. determining a time of arrival of an arterial pulse wavefront at the measuring site of the patient; b. emitting a first wavelength of electromagnetic radiation at the measurement site of the patient; c. measuring an intensity of the first wavelength of electromagnetic radiation at a first detector located at a first distance from the measurement site; d. measuring an intensity of the first wavelength of electromagnetic radiation at a second detector located at a second distance from the measurement site; e. emitting a second wavelength of electromagnetic radiation at the measurement site of the patient; f. measuring an intensity of the second wavelength of electromagnetic radiation at the first detector located at the first distance from the measurement site; g. measuring an intensity of the second wavelength of electromagnetic radiation at the second detector located at the second distance from the measurement site; h. determining a blood characteristic level, at a predetermined tissue level of interest, with an algorithm that filters out pulsatile signal contributions from a second predetermined tissue level, using the intensities of the first wavelength measured at the first detector and the second detector, using the intensities of the second wavelength measured at the first detector and the second detector, and rejecting blood characteristic level of venous blood of the patient.
References Cited (Backward Citations)
US4700708A
Cited
US5139025A
Cited
US4796636A
Cited
US5057695A
Cited
US5285783A
Cited
US5188108A
Cited
US5226417A
Cited
US5218962A
Cited
WO1992021283A1
Cited
US5277181A
Cited
US5372135A
Cited
US5297548A
Cited
DE4304693A1
Cited
US5524617A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-05-04 | 2001-11-03 | 2002-05-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-05-04 | 2005-11-03 | 2006-05-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-05-04 | 2009-11-03 | 2010-05-05 | $7700.00 | Window Closed / Lapsed |